Where Will IGC Pharma Inc (IGC) Stock Go Next After It Has Risen 15.79% in a Week?

IGC Pharma Inc (IGC) stock has risen 15.79% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

IGC Pharma Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IGC!

See Full IGC Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With IGC Stock Today?

IGC Pharma Inc (IGC) stock has risen 8.59% while the S&P 500 is lower by -0.37% as of 1:27 PM on Monday, Apr 1. IGC is higher by $0.03 from the previous closing price of $0.41 on volume of 616,262 shares. Over the past year the S&P 500 has risen 26.93% while IGC is higher by 25.71%. IGC lost -$0.25 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for IGC Pharma Inc click here.

More About IGC Pharma Inc

India Globalization Capital Inc is an investment holding company. The company's operating segment includes Infrastructure and Life Sciences. It generates maximum revenue from the Life Sciences segment. The Infrastructure Business segment involves the execution of construction contracts, the rental of heavy construction equipment, and the purchase and resale of physical commodities used in infrastructure. The Life Sciences Segment includes biopharmaceuticals and Over the Counter Products Geographically, it derives a majority of revenue from Hong Kong and also has a presence in India. Click Here to get the full Stock Report for IGC Pharma Inc stock.